BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Goncalves MV, Melo LH, Benedet CM, Ribas FD, Cabral NL, Fragoso YD. Eculizumab, Neuromyelitis Optica, and Tuberculosis: We Live An Era of Challenging Combinations. CNS Neurosci Ther 2015;21:914-5. [PMID: 26404521 DOI: 10.1111/cns.12465] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
Number Citing Articles
1 Lin J, Xue B, Li X, Xia J. Monoclonal antibody therapy for neuromyelitis optica spectrum disorder: current and future. Int J Neurosci 2017;127:735-44. [PMID: 27680606 DOI: 10.1080/00207454.2016.1242587] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
2 Godfrey MS, Friedman LN. Tuberculosis and Biologic Therapies: Anti-Tumor Necrosis Factor-α and Beyond. Clin Chest Med 2019;40:721-39. [PMID: 31731980 DOI: 10.1016/j.ccm.2019.07.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]